Clinical Trials Browser

Prostatic Neoplasms

Prostate Adenocarcinoma

Prostate Adenocarcinoma

Prostatic Neoplasms

Breast Neoplasms

Prostatic Neoplasms

Breast Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Breast Neoplasms

Breast Neoplasms, Breast Neoplasms, Male

Prostatic Neoplasms

Hormone Sensitive Prostate Cancer

Prostatic Neoplasms

Breast Neoplasms

Breast Neoplasms

Prostatic Neoplasms

Castrate Sensitive Prostate Cancer

Prostatic Neoplasms

Prostatic Neoplasms

PSA Level Greater Than Two

Breast Neoplasms

Prostatic Neoplasms

Breast Neoplasms

Castration-resistant Prostate Cancer Patients with Oligometastases

Carcinoma, Lobular

Breast Neoplasms

Prostatic Neoplasms, Radiation Injuries

Prostatic Neoplasms

Breast Neoplasms

Breast Neoplasms

Clinical Trials

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Roll-over Study to Allow Continued Access to Ribociclib

Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study

CARABELA

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer

PETREMAC

e3

CASPAR

Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors

STEEL

Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic

PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer

Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer

Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer

CARLHA-2

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

FACILE

PCS III

Study of Preservation of Ovarian Reserve During Chemotherapy for Young Breast Cancer Patients

PCS IX

ROSALINE

Detect V / CHEVENDO (Chemo vs. Endo)

Hypo-Combi

Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

PREDIX LumB

PREDIX LumA